Hypertriglyceridemia: New insights and new approaches to pharmacologic therapy

被引：47

作者：

Ginsberg, HN ^{[1
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, Dept Med, Div Prevent Med & Nutr, New York, NY USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 87卷 / 10期

关键词：

D O I：

10.1016/S0002-9149(01)01489-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A number of studies indicate that elevated triglyceride levels are an independent risk factor for the development of coronary heart disease. Although the National Cholesterol Education Program does not provide specific guidelines for therapy, management of hypertriglyceridemia should include lifestyle measures: if drug therapy is required, appropriate choices include nicotinic acid, fibrates, more potent statins. or combination therapy with a statin plus nicotinic acid or fibrates.

引用

页码：1174 / +

页数：49

共 57 条

[21] Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia
Ellen, RLB
McPherson, R
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) : 60B - 65B
[22] Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
Fard, A
Tuck, CH
Donis, JA
Sciacca, R
Di Tullio, MR
Wu, HD
Bryant, TA
Chen, NT
Torres-Tamayo, M
Ramasamy, R
Berglund, L
Ginsberg, HN
Homma, S
Cannon, PJ
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) : 2039 - 2044
[23] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
FRICK, MH
ELO, O
HAAPA, K
HEINONEN, OP
HEINSALMI, P
HELO, P
HUTTUNEN, JK
KAITANIEMI, P
KOSKINEN, P
MANNINEN, V
MAENPAA, H
MALKONEN, M
MANTTARI, M
NOROLA, S
PASTERNACK, A
PIKKARAINEN, J
ROMO, M
SJOBLOM, T
NIKKILA, EA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
[24] Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
Gardner, CD
Fortmann, SP
Krauss, RM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 875 - 881
[25] Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer
Ginsberg, HN
[J]. ANNALS OF INTERNAL MEDICINE, 1997, 126 (11) : 912 - 914
[26] ASSOCIATION OF POSTPRANDIAL TRIGLYCERIDE AND RETINYL PALMITATE RESPONSES WITH NEWLY-DIAGNOSED EXERCISE-INDUCED MYOCARDIAL-ISCHEMIA IN MIDDLE-AGED MEN AND WOMEN
GINSBERG, HN
JONES, J
BLANER, WS
THOMAS, A
KARMALLY, W
FIELDS, L
BLOOD, D
BEGG, MD
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) : 1829 - 1838
[27] INCREASED PRODUCTION-RATES OF LDL ARE COMMON IN INDIVIDUALS WITH LOW PLASMA-LEVELS OF HDL CHOLESTEROL, INDEPENDENT OF PLASMA TRIGLYCERIDE CONCENTRATIONS
GINSBERG, HN
NGAI, C
WANG, XJ
RAMAKRISHNAN, R
[J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06): : 842 - 851
[28] 2 DIFFERENT VIEWS OF THE RELATIONSHIP OF HYPERTRIGLYCERIDEMIA TO CORONARY HEART-DISEASE - IMPLICATIONS FOR TREATMENT
GRUNDY, SM
VEGA, GL
[J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (01) : 28 - 34
[29] Small LDL, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, SM
[J]. CIRCULATION, 1997, 95 (01) : 1 - 4
[30] Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014

← 1 2 3 4 5 6 →